Back to results
US 2014/0179916 A1Published application
Forms of rifaximin and uses thereof
AssigneeSalix Pharmaceuticals, Inc.
InventorsKaren S. Gushurst, Donglai Yang, Petinka Vlahova, Jeffrey S. Stults
Life of this patent
Estimating the term…
Abstract
The present invention relates to Rifaximin polymorphic forms, to their use in medicinal preparations and to therapeutic methods using them.
Claims20
Polymorphic Form ζ, Form η, Form ι, Form ι-dry, Form ι-dry′, or Form B of rifaximin.
A pharmaceutical dosage form comprising one or more of polymorphic Form ζ, Form η, Form ι, Form ι-dry, Form ι-dry′, or Form B of rifaximin or mixtures thereof.
Dependencies are inferred from the claim text.